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Paternal under-nutrition 
programs metabolic syndrome in 
offspring which can be reversed 
by antioxidant/vitamin food 
fortification in fathers
Nicole O. McPherson1,2, Tod Fullston1, Wan Xian Kang1, Lauren Y. Sandeman1, 
Mark A. Corbett3, Julie A. Owens1 & Michelle Lane1,4
There is an ever increasing body of evidence that demonstrates that paternal over-nutrition prior to 
conception programs impaired metabolic health in offspring. Here we examined whether paternal 
under-nutrition can also program impaired health in offspring and if any detrimental health outcomes 
in offspring could be prevented by micronutrient supplementation (vitamins and antioxidants). 
We discovered that restricting the food intake of male rodents reduced their body weight, fertility, 
increased sperm oxidative DNA lesions and reduced global sperm methylation. Under-nourished males 
then sired offspring with reduced postnatal weight and growth but somewhat paradoxically increased 
adiposity and dyslipidaemia, despite being fed standard chow. Paternal vitamin/antioxidant food 
fortification during under-nutrition not only normalised founder oxidative sperm DNA lesions but also 
prevented early growth restriction, fat accumulation and dyslipidaemia in offspring. This demonstrates 
that paternal under-nutrition reduces postnatal growth but increases the risk of obesity and metabolic 
disease in the next generation and that micronutrient supplementation during this period of under-
nutrition is capable of restoring offspring metabolic health.
Worldwide, under-nutrition is a common affliction that affects 870 million adults and children, accounting for 
55% of global morbidity and mortality, with pregnancy, perinatal and childhood periods being particularly sen-
sitive1. Maternal under-nutrition both before and during pregnancy can restrict fetal growth and can program 
offspring for increased risks of noncommunicable diseases (NCDs)2, such as increased risks of cardiovascular 
disease and type II diabetes in children; as documented for the children born during the Dutch famine for exam-
ple3. Data from Sweden also implicates a paternal origin for under-nutrition based programming, with grand-
paternal famine associated with obesity and cardiovascular disease in grandchildren4. However the impact on 
the first generation and whether this relationship between a grandfather’s food restriction and their grandchild’s 
metabolic disorders is causal remains unclear. Other models of paternal programming (i.e. over-nutrition) report 
impairment to the health of both first and second generation offspring, manifesting as an increased risk of meta-
bolic syndrome and subfertility5–7. This paternal programming from over-nutrition may act, in part, by oxidative 
stress in both testes and sperm8–10 that ultimately leads to adverse embryo, fetal and placental growth11–13. Here 
we examined the effects of paternal under-nutrition on growth, metabolic homeostasis and gene expression in 
offspring, and whether oxidative stress (as measured by reactive oxygen species; ROS) in sperm is a mediating 
factor. We induced under-nutrition in male mice by restricting dietary food intake (DR) to 70% of ad libitum 
controls (CD) for 17 weeks (Table S1) and examined the effects in juvenile and adult offspring.
1Discipline of Obstetrics and Gynaecology, School of Medicine, Robinson Research Institute, University of Adelaide, 
South Australia, 5005, Australia. 2Freemasons Centre for Men’s Health, University of Adelaide, South Australia, 5005, 
Australia. 3Discipline of Paediatrics, School of Medicine, Robinson Research Institute, The University of Adelaide, 
South Australia 5005, Australia. 4Monash IVF Group, Melbourne, Victoria, 3168, Australia. Correspondence and 
requests for materials should be addressed to N.O.M. (email: nicole.mcpherson@adelaide.edu.au)
Received: 02 September 2014
Accepted: 11 May 2016
Published: 03 June 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:27010 | DOI: 10.1038/srep27010
Under-nutrition and its associated comorbidities have been combatted in developing countries through 
micronutrient supplementation and food fortification14, typically by supplementing folate, iron and zinc in 
undernourished children and women of reproductive age14. Many of these micronutrients act as antioxidants, 
known to reduce oxidative lesions in sperm15. We therefore examined whether micronutrient supplementation 
of undernourished males could reverse or prevent any adverse outcomes to sperm and subsequent offspring. To 
achieve this we fortified their food during DR with vitamins/antioxidants (DRVO, Table S1). All males were then 
mated with normal weight ad libitum fed female mice, who were allowed to litter, and then their offspring were 
assessed.
Results
Founder diet restriction reduces body weight, impairs sperm function and global methylation, 
and impacts preimplantation embryo development. DR and DRVO reduced body weight, adipose 
depots (gonadal, omental, renal and dorsal) plasma leptin and corticosterone, but improved glucose and insulin 
tolerance in founder males, compared with CD (P < 0.05, Table 1). There was no effect of DR on sperm count, 
motility or morphology, however DR increased sperm ROS and oxidative DNA lesions (P < 0.05, Table 2), which 
were restored by DRVO (Table 2). Further assessment of sperm function included it’s capacity to bind to the zona 
pellicuda, which demonstrated a reduction in the numbers of sperm bound to oocytes following IVF using sperm 
from DR males compared with CD males (P < 0.05, Table 2). Again sperm-oocyte binding was restored by DRVO. 
However supplementation of a CD cohort with antioxidant and vitamins (CDVO) did not affect any parameter 
measured that has previously been associated with inducing an offspring phenotype including body composition 
measures (weight or adiposity; Table 1), glucose or insulin tolerance or sperm parameters (count, motility, ROS 
levels, or sperm binding ; Table 2) and therefore this cohort was not investigated further.
For embryo development DR increased 2-cell cleavage rates compared with CD (P < 0.05, Table 2), but by 
78 h of culture also displayed delayed blastocyst development (P < 0.05, Table 2), both of which were restored 
by DRVO (Table 2). By 96 h of culture no change in blastocyst development or blastocyst cell number was seen 
between treatments (P > 0.05, Table 2). DR did not alter mating frequency, time to mate, gestational length or lit-
ter size, but did reduce fertility (decreased pregnancy rates post-successful mating) and the proportion of female 
offspring (P < 0.05, Table 2). Pregnancy rates and female/male offspring ratios were normalised in DRVO males 
(P < 0.05, Table 2).
As altered levels of dietary folate have previously been shown to alter the methylation status of sperm16 and 
our VO group included the addition of folic acid (the synthetic form of folate) we further assessed the global 
methylation (5 mC) by immunocytochemistry in sperm. 5mC levels in sperm were low in all treatment groups 
(0–3% of sperm which stained positive, Table 2). Interestingly 5mC were reduced in DR compared with CD 
(P < 0.05, Table 2, Fig. S1) and was partially restored by DRVO (p = 0.06, Table 2, Fig. S1).
Diet restricted fathers reduce offspring postnatal weight, growth, alter adiposity accumulation 
and size. Founder DR reduced male and female offspring weights postnatally (d5–d21; P < 0.05, Fig. 1A,D) 
and reduced pre-weaning weight gain (Fig. 1B,F). Sons showed slower growth until 6 weeks of age (P < 0.05, 
Fig. 1C, Table S2) followed by a ‘catch up growth’ phase, resulting in similar weight to CD by 7 weeks (P < 0.05, 
CD (n = 10) CDVO (n = 10) DR (n = 10) DRVO (n = 10)
Total body weight (g) 30.8 ± 1.0a 30.2 ± 0.7a 23.3 ± 0.4b 22.3 ± 0.5c
Weight gained (g)* 13.7 ± 0.7a 13.2 ± 0.6a 7.1 ± 0.4b 5.8 ± 0.4c
Weight gained (%)* 76.2 ± 3.2a 73.2 ± 2.8a 40.9 ± 2.3b 33.5 ± 2.2c
Adiposity
    Gonadal fat (%) 3.47 ± 0.30a 3.23 ± 0.30a 2.04 ± 0.11b 1.58 ± 0.17c
    Omental fat (%) 1.48 ± 0.03a 1.26 ± 0.09a 0.86 ± 0.09b 0.77 ± 0.06b
    Renal fat (%) 1.41 ± 0.13a 1.39 ± 0.11a 0.69 ± 0.06b 0.53 ± 0.05c
    Dorsal fat (%) 1.18 ± 0.09a 1.07 ± 0.12a 0.74 ± 0.06b 0.74 ± 0.05b
    Sum of fat depots (%) 7.51 ± 0.52a 6.96 ± 0.55a 4.33 ± 0.28b 3.62 ± 0.25c
Plasma Metabolites and hormones, glucose and insulin tolerance
    Glucose (mmol/L−1) 10.95 ± 0.49a 10.11 ± 0.33a 7.16 ± 0.17b 6.76 ± 0.14b
     Glucose tolerance (AUC,  
min.mmol) 847.1 ± 75.7
a 676 ± 62.6a 259.4 ± 10.3b 307.8 ± 14.1b
    Insulin (ng/mL−1) 0.31 ± 0.07 0.46 ± 0.13 0.26 ± 0.05 0.35 ± 0.07
     Insulin tolerance (AAC, 
min.mmol) 228.2 ± 27.5
a 264.4 ± 54.0a 390.3 ± 54.2b 389.0 ± 60.9b
    Leptin (ng/mL−1) 6.67 ± 0.98a 6.46 ± 1.6a 1.58 ± 0.18b 1.17 ± 0.11b
    Corticosterone (ng/mL−1) 202.6 ± 29.3a 155.4 ± 60.5a 160.6 ± 26.8a,b 128.6 ± 16.1b
Table 1.  Founder Male Body Composition and Metabolites. Statistical significance was assessed by one 
way ANOVA, with a Bonferroni post hoc test. * Weight gain was calculated by total body weight prior to diet 
restriction (5 weeks of age) and total body weight prior to post mortem (22 weeks of age). Data are expressed 
as mean ± SEM. Different letters denote significance at P < 0.05. No superscripts are used where no statistical 
differences were found.
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Fig. 1C,D). Prenatal and early postnatal growth restriction is known to be associated with changes in body com-
position, including increased adiposity later in life17. Interestingly, founder DR increased relative (to total body 
weight) fat mass in sons at 4 weeks (P < 0.05, Fig. 2A), but this dissipated by 8 weeks of age (Fig. 2A,B, Table S2). 
At 15 weeks of age sons had reduced fat mass in selected central and peripheral fat depots in both absolute and 
relative terms (P < 0.05, Fig. 2C, Table S4) and reduced adipocyte cell size in omental fat depot (Fig. 3A) (P < 0.05, 
Fig. 3B,D), while the number of adipocytes was increased, indicating greater cell density (P < 0.05, Fig. 3C,D). 
At this same age DR sons had increased circulating lipids (total cholesterol and triglycerides (P < 0.05, Fig. 2D) 
and free fatty acids (FFA, P < 0.05, Fig. 2E). Interestingly, DR sons had improved insulin sensitivity at 14 weeks 
(p < 0.05, Fig. S3B,C).
In contrast, DR daughters had reduced relative fat mass at 4 weeks of age (P < 0.05, Fig. 2F, Table S3), however 
accumulated more body fat as they matured (P < 0.05, Fig. 2G) resulting in normal adult adiposity (Fig. 2F,H, 
CD (n = 10) CDVO (n = 10) DR (n = 10) DRVO (n = 10)
Sperm Measures
    Sperm count (× 106) 20.7 ± 3.2 19.5 ± 2.4 23.3 ± 2.8 20.9 ± 1.6
    Total sperm motility (%) 71.8 ± 2.8 67.4 ± 2.1 68.3 ± 4.4 64.7 ± 3.4
     Normal sperm morphology (%) 33.4 ± 2.2 37.8 ± 2.5 36.9 ± 1.9 36.1 ± 2.5
     Number of sperm bound to a 
MII oocyte 55.1 ± 1.2
a 54.6 ± 2.0a 34.5 ± 1.2b 54.0 ± 1.1a
Oxidative sperm DNA damage
    8-OH-dG positive sperm (%) 4.0 ± 0.4 (2.1–5.1)a
0.9 ± 0.2 
(0.0–2.0)b
6.3 ± 1.6 
(2.5–11.1)a
4.4 ± 0.8 
(2.0–6.4)a
     Proportion of males with > 75% 
quartile sperm positive for 
8-OH-dG
0a 0a 50b 0a
     Sperm ROS levels (DCFDA) 
(FU)
472 ± 6 
(413–536)
442.3 ± 34.5 
(134–811)
490 ± 30 
(224–1000)
478 ± 18 
(254–670)
     Proportion of sperm with > 75% 
quartile ROS 0
a 16.7a,b 39b 17a,b
     Correlation of sperm 8-OH-dG 
with sperm ROS
CCO = 0.578, 
p = 0.02
Global sperm methylation
    Sperm positive for 5mC (%) 0.79 ± 0.21
a 
(0–1.32)
1.66 ± 0.58a 
(0.73–3.19)
0.38 ± 0.07b 
(0–0.54)
1.13 ± 0.47a,& 
(0.36–3.43)
Embryo Development
     2-cell cleavage (20 h culture) (%) 72.3a 72.2a 86.9b 76.9a,b
     8-cell/compacting (42 h culture) 
(%) 77.2
a 75.2a 70.0a 84.3b
     Exp blast developed (78 h 
culture) (%) 84.5
a 90.7a 65.7b 82.9a
     Total blast developed (96 h 
culture) (%) 96.1 94.1 94.7 94.2
Embryo cell numbers (96 h culture)
    Total cell number 55.0 ± 2.2 52.5 ± 2.1 56.2 ± 4.0 50.5 ± 1.7
    Trophectoderm cell number 45.4 ± 2.0 42.2 ± 1.8 46.4 ± 3.7 41.4 ± 1.6
    Inner cell mass cell number 9.6 ± 0.5 10.3 ± 0.5 9.8 ± 0.9 9.1 ± 0.4
Mating and litter size
    Mating rate (%) 96.3 100 93.1
    Pregnancy rate (%) 50.0a 25.0b 44.4a
    Time to mate (days) 1.95 ± 0.30 2.04 ± 0.26 1.64 ± 0.26
    Gestational length (days) 19.4 ± 0.2 19.1 ± 0.1 19.5 ± 0.2
    Litter size 7.08 ± 0.45 7.13 ± 0.24 7.09 ± 0.32
    Female offspring (%) 59a 31b 46a,b
Table 2.  Founder Male Fertility. Embryo development data represents at least 100 embryos from 6 fathers per 
treatment. Proportional embryo development data was analyzed by a Fisher’s exact test. Mating and litter data 
represents 7 litters generated from 6 founders for CD group, 6 litters generated from 6 founders for DR group 
and 8 litters generated from 8 founders for the DRVO group. Data was averaged for each founder then analyzed 
by a one way ANOVA, with a Bonferroni post hoc test. Mating rates were determined by the number of females 
with copulation plugs and pregnancy rates were calculated based on number of plugged females that produced 
a litter. Oxidative sperm DNA damage was assessed in founders who produced offspring. Data are expressed as 
mean ± SEM. FU = Fluorescent units. CCO = correlation coefficient. Number in brackets following oxidative 
sperm DNA damage and global methylation represent lowest and highest values for the group. Different letters 
denote significance at P < 0.05. &Different to DR at p = 0.06. No superscripts are used where no statistical 
differences were found.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:27010 | DOI: 10.1038/srep27010
Tables S3 and S5), with omental adipocyte cell size and density not altered at 15 weeks (Fig. 3E–H). DR daughters 
had increased circulating total and HDL cholesterol (P < 0.05, Fig. 2I) at 15 weeks, despite normal adiposity, again 
suggesting impaired lipid metabolism and homeostasis. DR daughters also had reductions in fasting and fed 
Figure 1. Vitamin and antioxidant supplementation of under nourished fathers restores neonatal size and 
growth. (A) Early postnatal growth of male offspring until weaning (21 days old). (B) Total weight gained in 
male offspring from day 5 until day 21. (C) Weights of male offspring from 4 weeks until 14 weeks. (D) Male 
offspring total amount of weight gained post weaning from 4 weeks of age until 14 weeks. (E) Early postnatal 
growth of female offspring until weaning (21 days old). (F) Total weight gained in female offspring from day 
5 until day 21. (G) Weights of female offspring from 4 weeks until 14 weeks. (H) Female offspring total weight 
gained post weaning from 4 weeks until 14 weeks. Data represents 28 male and 40 female offspring from 7 
litters representing 6 founder males for CD, 37 male and 17 females from 6 litters representing 6 founder males 
for DR and 40 male and 35 female offspring from 8 litters representing 8 founder males for DRVO. Statistical 
significance was determined by repeated measures ANOVA, with founder ID added as a random factor to 
both pre and post weaning weights and mother ID added as a random factor to pre weaning weights, to adjust 
outcomes for offspring generated from the same founder and same mother. Data is expressed as mean ± SEM. 
Different letters denote significance at P < 0.05; +denotes significance to CD and DRVO at p = 0.06.
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plasma glucose at 8 weeks (p < 0.05, Fig. S2D) and at 14 weeks (p < 0.05, Fig. S3E) respectively, but no alterations 
in glucose tolerance or insulin tolerance at these ages (Fig. S3).
Figure 2. Vitamin and antioxidant supplementation of under nourished fathers restores male and female 
offspring adiposity and circulating lipids, insulin and leptin in female offspring. (A) Total adiposity as 
a percentage of body weight in male offspring as measured by DEXA at 4, 8 and 14 weeks of age. (B) Total 
adiposity gained (4 to 14 weeks) in male offspring as a percentage of fat mass at 14 weeks as determined by 
DEXA. (C) Sum of adipose depots (omental, gonadal, renal and dorsal) as a percentage of body weight at 15 
weeks for male offspring. (D) Fasted serum lipids in male offspring at 15 weeks. (E) Fasted free fatty acids, leptin 
and insulin levels in male offspring at 15 weeks. (F) Total adiposity as a percentage of body weight in female 
offspring as measured by DEXA at 4, 8 and 14 weeks. (G) Total adiposity gained (4 to 14 weeks) in female 
offspring as a percentage of fat mass at 14 weeks as determined by DEXA. (H) Sum of adipose depots (omental, 
gonadal, renal and dorsal) as a percentage of body weight at 15 weeks for female offspring. (I) Fasted serum lipids 
in female offspring at 15 weeks. (J) Fasted free fatty acids, leptin and insulin levels in female offspring at 15 weeks. 
Data represents 14 females and 14 males from 7 litters generated from 6 founders for CD group, 12 females 
and 12 males from 6 litters generated from 6 founders for DR group, and 16 females and 16 males from 8 litters 
generated from 8 founders for the DRVO group. Statistical significance was determined by repeated measures 
ANOVA, with founder ID added as a random factor for adiposity data and a general linear mixed model with 
founder ID added as a random factor for all other measures to adjust outcomes for offspring generated from the 
same founder. Data is expressed as mean ± SEM. Different letters denote significance at P < 0.05.
www.nature.com/scientificreports/
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Vitamin and antioxidant supplementation to diet restricted fathers reverse postnatal weights 
and adult adiposity. Other paternal nutritional manipulations that initiate paternal programming impli-
cate oxidative stress in sperm as a potential mediator5,6,18. Thus we examined if paternal supplementation with 
vitamins/antioxidants known to reduce sperm ROS15 during DR in fathers (DRVO) could rescue offspring 
phenotypes. Founder DRVO normalised both male and female offspring weight, growth and adiposity both 
pre-weaning (P < 0.05, Fig. 1A,B,E,F) and post-weaning (P < 0.05, Fig. 1C,D,G,H), to that of offspring born 
to CD. Both DRVO sons and daughters had restored adiposity accumulation and adipocyte phenotypes, com-
pared with DR offspring (P < 0.05, Figs 2 and 3, Tables S2, S3, S4 and S5). Founder DRVO did not normalise 
Figure 3. Vitamin and antioxidant supplementation of under nourished fathers restores male offspring 
adipocyte number and size. (A) Male offspring omental fat as a percentage of total body weight at 15 weeks. 
(B) Male offspring adipocyte cell size of omental fat at 15 weeks. (C) Male offspring adipocyte cell number at 15 
weeks. (D) Male offspring omental fat cell size representative pictures for each founder treatment (40x).  
(E) Female offspring omental fat as a percentage of total body weight at 15 week PM. (F) Female offspring 
fat cell size of omental fat at 15 weeks. (G) Female offspring fat cell number at 15 weeks (H) Female offspring 
omental fat cell size representative pictures for each founder treatment (40x). Omental fat percent of total body 
weight represents 14 females and 14 males from 7 litters generated from 6 founders for CD group, 12 females 
and 12 males from 6 litters generated from 6 founders for DR group, and 16 females and 16 males from 8 litters 
generated from 8 founders for the DRVO group. Adipocyte number and size represents 4 males and 4 females 
from 4 litters generated from 4 founders for each treatment group. Statistical significance was determined 
with a general linear mixed model, with founder ID added as a random factor to adjust outcomes for offspring 
generated from the same founder. Data is expressed as mean ± SEM. Different letters denote significance at 
P < 0.05.
www.nature.com/scientificreports/
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the elevated plasma total cholesterol, triglycerides or FFA in adult sons (Fig. 2E,D). However, circulating lipids 
were improved in DRVO daughters, with reductions of plasma total and HDL cholesterol comparable to CD off-
spring (Fig. 2I). Furthermore, DRVO daughters had reduced plasma leptin and insulin compared to CD offspring 
(P < 0.05, Fig. 2J). Similar to DR founder DRVO improved insulin sensitivity at 8 weeks of age in sons (P < 0.05, 
Figs S2A, S3C), although this was not seen by 14 weeks (Fig. S2B,C); the age when DR son’s improved insulin 
sensitivity was significant. Although there were no changes to insulin and glucose tolerance in DRVO daughters at 
8 and 14 weeks of age, they maintained lower fasting and fed glucose levels prior to the 8 week GTT and 14 week 
ITT (Fig. S3D,E), similar to that of DR daughters.
Founder oxidative status in sperm correlates with male offspring postnatal growth. In nor-
mal weight men supplementation of vitamins/antioxidants has been shown to be beneficial to sperm health19–21 
with specific reductions in ROS mediated sperm DNA lesions in a sub-fertile population15. Consistent with this, 
we saw a greater proportion of DR males with increased sperm oxidative DNA lesions, which was reduced in 
DRVO (P < 0.05, Table 2) and a positive correlation between sperm 8-OH-dG levels and sperm ROS (P < 0.05, 
Table 2). Sperm DNA 8-OH-dG, a marker of oxidative lesions, correlated negatively with son’s postnatal weight, 
independent of founder diet (p < 0.01, d5 − 0.260; d7 − 0.304; d10 − 0.350; d14 − 0.424; d21 − 0.374 and weight 
gained − 0.374), however this was not evident in daughters.
Diet restriction in fathers alters gene expression in offspring in a sex specific manner with par-
tial normalisation by vitamin and antioxidant supplementation. Changes to the gene expression 
of pancreas have been reported for other models of paternal nutritional programing of offspring phenotype7,22, so 
the effect of DR and DRVO were investigated in the pancreas of offspring.
When offspring where analysed regardless of sex, paternal DR altered the expression of Vaultrc5, Arl1, and 
Casp9 in pancreas compared with CD (FDR < 0.05), but DRVO did not affect their expression compared with DR 
(Supplementary Table S6).
Male offspring fathered by DR males had reduced expression of Gm20594 and Lars2 in pancreas compared with 
CD (FDR < 0.05), but again DRVO did not affect their expression compared with DR (Supplementary Table S6).
Female offspring fathered by DR males had alteration to 14 genes in the pancreas compared with CD 
(FDR < 0.05; Supplementary Table S6). Interestingly 5/14 were normalised by DRVO (Casp9, Ctsf, Sec14l4, 
Snord22, Tmem38b) to an abundance equivalent to CD (Fig. 4), whereas the remaining 8/14 were not. An analysis 
of enrichment of gene ontology terms in differentially expressed genes23 in female offspring due to paternal DR 
revealed a pattern of genes involving developmental processes. Specific gene ontologies that were enriched in 
differentially expressed genes include apoptosis, organogenesis, neuronal cell fate/differentiation, pattern specifi-
cation, cell projection organisation (lamellipodium) and G-coupled receptor signaling.
When differential gene expression was analysed regardless of sex, in male offspring only, and in female off-
spring only 1 (Vaultrc5), 2 (Gm20594, Lars2), and 4 (Snord15b, Snord15a, Snord17, Eif5a) genes, respectively, were 
down-regulated by DR (DR and DRVO fathers) regardless of micronutrient supplementation (Supplementary 
Table 6; blue highlight). Conversely micronutrient supplementation (DRVO) dysregulated 5 genes (3 up-regulated 
– miR-2137, Gm20594, miR-5109; 2 down-regulated – 3110062M04Rik, Dmp1) in pancreas of female offspring 
regardless of diet restriction (Supplementary Table 6; green highlight); but this phenomena was not seen when 
analysis was performed regardless of offspring sex nor in male offspring only.
It must be noted that there was a greater number of adult pancreas genes with altered expression in DRVO 
compared with CD, than DR vs CD for all groups. For example when data was analysed regardless of offspring 
sex 4 genes were altered by DRVO, 3 of which were not altered by DR alone, compared with CD. In male offspring 
7 genes were altered by DRVO, 5 of which were not altered by DR alone, compared with CD. Finally in female 
offspring DRVO altered the expression of 60 genes; 56 were not also altered by DR, compared with CD.
Discussion
Paternal under-nutrition of specific dietary components including low protein diet and folate insufficiency, or in 
utero under nutrition in males has previously been shown to alter fertility and increase offspring susceptibility 
to cardiovascular disease and metabolic syndrome16,24,25. Our study confirms these findings in a mouse model of 
70% caloric restriction, designed to mimic the environment of a developing country. The subsequent assessment 
of the effects to fertility and offspring health was also extended to determine if these phenotypes could be reversed 
through vitamin and antioxidant food fortification to our under nourished founder males. We show for the first 
time that reduced offspring weight, dyslipidemia and adipose accumulation, and altered pancreas gene expres-
sion that resulted from paternal under-nutrition can be restored by vitamin and antioxidant food fortification 
in fathers. Additionally we show that diet restriction increases oxidative sperm DNA lesions and reduces global 
sperm methylation which were also somewhat normalised by food fortification.
70% diet restriction with or without vitamin and antioxidant supplementation reduced founder male body 
weight, adiposity and plasma leptin and corticosterone levels while improving glucose and insulin regulation 
similar to other rodent models of caloric restriction26,27. Interestingly there was no effect of DR on commonly 
assessed fertility parameters (sperm count, motility or morphology) used in fertility clinics to assess male fer-
tility28. However, DR did decrease the number of sperm that could bind to an MII oocyte, indicating a potential 
decrease in post ejaculation sperm maturation (capacitation and hyperactivation) both necessary requirements 
for sperm binding29. Sperm binding also utilizes glucose30, and the reduced circulating glucose concentrations in 
DR males may have also contributed to their reduced sperm binding. Interestingly this reduced sperm binding 
from DR fathers did not alter bound sperm’s capacity to fertilize oocytes, with DR males displaying increased 
2-cell cleavage rates, indicating that their reduced sperm binding was likely of no immediate biological signif-
icance. But it must be noted that by 78 h of embryo culture DR males did have a reduction in the number of 
www.nature.com/scientificreports/
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blastocysts that developed. Increased levels of sperm ROS and oxidative DNA lesions in vitro, as seen here in DR 
males, has previously been demonstrated to reduce blastocyst formation without altering 2-cell cleavage rates or 
the total cell number if blastocysts18.
While there were no changes to mating rates as evident by a vaginal copulation plug, the number of plugged 
females that went on to make a successful litter were reduced for DR males. In humans it has been shown that 
delayed on time embryo development is associated with reduced embryo implantation31, and therefore the 
delayed on time blastocyst development seen at 78 hours of culture may have contributed to reduced embryo 
viability. Interestingly the sex ratio of pups was altered by DR with DR fathers producing more male offspring, 
which is consistent with the model of paternal protein restriction24. This suggests DR may have altered the molec-
ular composition of sperm, consistent with other experimental paradigms of paternal programming6,24,32. The 
unchanged litter size and sperm function suggests that paternal DR alters offspring sex ratio, potentially by altered 
proportions of X/Y chromosome bearing sperm impairing individual function33. Given that the gene expression 
due to DR was most changed in the pancreases of adult female offspring at 15 weeks of age, compared with male 
offspring, perhaps X chromosome bearing sperm are more sensitive to the changes that enact the transmission. 
Interestingly, 5 of the 14 genes dysregualted in the pancreas of female offspring sired by paternal diet restriction 
were restored to the same abundance as female’s born to control fathers by micronutrient supplementation during 
diet restriction. Although it must be noted that more genes were altered by the combination of diet restriction 
with micronutrient supplementation than were rescued, two distinct subsets of dysregulated genes were unique 
to either diet restriction or micronutrient supplementation, and that the altered expression of these genes in 
offspring tissue as a result of paternal nutritional programming has not been previously reported. It is enticing 
to speculate that the alteration of the expression of these 5 genes due to paternal diet restriction and their nor-
malisation by micronutrient fortification during diet restriction suggests that they may be altered/restored by 
the same mechanism that also causes/restores offspring phenotype – albeit manifesting only in female offspring. 
For example the up-regulation of Casp9 may imply an increased apoptosis within the pancreas and might partly 
explain some of the metabolic defects observed in female offspring. The dysregulation of the other 4 genes have 
also been associated with human and animal pathologies, warranting further validation/investigation; including 
mutations in Tmem38b that are associated with reduced bone mass, and reduced Ctsf abundance associated with 
aberrant neural cell growth. Furthermore, the gene expression results highlight the importance of analysing male 
and female offspring as separate entities.
Similar to previous mouse models of paternal nutrient restriction (protein and folate)16,24 as well as paternal 
over nutrition6,7 we observed sex specific effects to offspring metabolic health. DR reduced both male and female 
Figure 4. Vitamin and antioxidant supplementation of under nourished fathers partially restores gene 
expression the pancreas from female offspring. Box plots represent the gene expression by RNA sequencing 
of the pancreas from 6 female offspring each selected from a different litter per paternal diet group. Differential 
expression was determined between groups by first fitting a generalised linear model to these data incorporating 
diet of the father, sex of the mouse and RIN scores as covariates. Differences between groups with fathers fed 
under different diet conditions were determined by log rank test, correcting for multiple testing with the false 
discovery rate method. Data is expressed as log2 of the mean from the 6 samples of normalised reads per 
kilobase per million reads (RPKM) per transcript ± SEM. * Significantly different to the pancreatic expression of 
that gene in female offspring born to CD founder (FDR < 0.05; p < 0.001).
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neonatal and post natal weights up until weaning, followed by a period of ‘catch up growth’ in early adulthood. 
This phenotype follows a similar pattern to that of small for gestational age children who are born small and 
then display this catch up growth. Prenatal and early postnatal growth restriction is known to be associated with 
increased incidence of metabolic health problems later in life17. Male offspring of DR fathers had increased fat 
mass at 4 weeks of age, which manifested as increased adipocyte cell numbers without an increased in fat mass 
by 15 weeks of age, similar to that of male offspring born to fathers exposed to low protein diets24. Thus DR 
sons may have an increased propensity to deposit fat if challenged by an obesogenic environment later in life34. 
This double hit phenomenon of (1) parental peri-conception challenge followed by (2) adult offspring environ-
mental exposure is seen in many developing countries where under-nutrition and obesity co-exist35,36. By 15 
weeks of age male offspring had increase plasma lipid concentrations (cholesterol, triglycerides and FFA) sug-
gesting impaired lipid metabolism and homeostasis. A similar phenotype has been reported by paternal protein 
restriction, which increased hepatic cholesterols in offspring, presumably due, in part, to altered expression of 
transcripts (Hmgcr, Pmvk, Sqle and Sc4mol) which target SREBP; a major transcriptional regulator of cholesterol 
metabolism37. Female offspring of DR fathers had reduced fat mass at 4 weeks of age, however, gain more adipose 
tissue throughout life, so that by 15 weeks of age they demonstrated similar adiposity to that of control offspring. 
This period of increased fat deposition coincided with abnormal plasma lipid profile. Whether the underlying 
mechanism driving their elevated total and HDL cholesterol and increased rate of fat accumulation will result in 
obesity later in life is unclear. However, the DR daughter phenotype is reminiscent of the phenotype observed in 
Senegalese girls, who as a result of under-nutrition and stunted growth as children, have increased accumulation 
of relative body fat during puberty, with greater deposition of subcutaneous fat in central and upper regions of 
their bodies at fifteen years of age38. The reduced female offspring plasma glucose concentration observed here 
due to paternal DR has been previously shown, whereby founder male rodents were fasted for 24h prior to mating 
that led to reduced serum glucose in offspring by 6 weeks of age39. Interestingly we saw no effects to glucose or 
insulin tolerance testing from our offspring sired by DR fathers. Whether additional and more marked changes 
would emerge as offspring age as seen in a setting of paternal protein restriction (at 22 weeks of age)24, or even 
as a secondary consequence to their abnormal lipid profiles at 15 weeks, remains to be determined. Of note, in 
some experimental paradigms of paternal nutritional manipulation, systemic phenotypic changes in metabolism 
emerge only later in life in aged offspring6,7,24 with only changes at the molecular level observed in early life7,22.
One hypothesis for the generation and transmission of paternally-mediated pathologies to offspring, which 
involves the incomplete repair of sperm DNA lesions at fertilisation, has been suggested by Aitken and col-
leagues40. Sperm are highly susceptible to ROS as they have lost most of their cytoplasmic scavenging enzymes 
during maturation (spermiogenesis)41,42, their plasma membrane contains large quantities of polyunsaturated 
fatty acids which are particularly susceptible to ROS43, and when released into the epididymis they have left the 
protection of the blood testes barrier. At fertilisation, the oocyte has a limited capacity to repair these oxidative 
DNA lesions, and therefore incomplete or aberrant repair of these oxidative DNA lesions hold the potential to 
create mutations which could inhabit every cell of the subsequent embryo/offspring. This hypothesis is highly 
relevant to our findings, as increased ROS and oxidative DNA lesions were elevated in sperm of DR fathers, and 
could be a contributing factor to the impairments observed in their offspring phenotypes. The artificial induction 
of oxidative stress in mouse sperm by H2O2 also resulted in reduced postnatal growth and increased adiposity in 
both male and female offspring18, similar to the phenotypes reported for this DR model.
Interestingly all effects from DR on male sperm function, ROS levels, oxidative DNA lesions, embryo devel-
opment, pregnancy establishment, sex specific effects on offspring metabolic health and some sex specific pan-
creas gene expression differences were normalised by antioxidant and vitamin food fortification of DR fathers. 
Micronutrient supplementation (vitamin E, vitamin C, zinc, folate, selenium) to infertile men has previously 
been shown to reduce seminal ROS levels after 3 months of antioxidant treatment15. It is therefore likely that the 
reductions to sperm ROS and oxidative DNA lesions result from the antioxidant supplementation. The epididy-
mal endothelial ion transporters operate between the circulating blood and epididymial lumen44,45, allowing for 
ingested antioxidants to come into contact with the sperm during this important transitional step and to degrade 
free radicals, reducing the number of oxidative lesions. This suggests that improvements to offspring growth, adi-
pose accumulation and lipid accumulation due to an undernourished father maybe reversed through reductions 
to sperm ROS via antioxidant and vitamin food fortification.
Other potential mechanisms for paternal programming also include epigenetic changes to sperm (small non 
coding RNAs, methylation, and histone changes) and seminal fluid composition. This is evidenced by chem-
ically induced site specific changes to sperm DNA methylation within the male pronucleus being associated 
with increased post-implantation pregnancy loss46, aberrant abundance of sperm microRNAs programming off-
spring phenotypes47, and altered seminal fluid composition inducing pregnancy loss and programming meta-
bolic disease in offspring48. Relevant to this study, models using low folate diets (folate is a known methyl donor) 
demonstrate changes to sperm methylation at the promoters of genes important for developmental and metabolic 
processes16, and that in zebra fish the sperm methylome is inherited by the embryo at fertilisation49. Interestingly, 
DR males had a reduced number of sperm nuclei positive for 5mC methylation staining, which tended towards 
normalisation by antioxidant and vitamin food fortification (i.e. p = 0.06). However, it should be noted that the 
abundance of 5mC detected in mouse sperm by immunocytochemistry was low and detection of 5mC was likely 
limited due to the tight packaging of mouse DNA around protamines (99%), even the after DNA denaturing and 
condensation steps used in the protocol. Further studies assessing site specific methylation patterns of develop-
mental, metabolic, and paternally imprinted genes and whether changes are caused by DR and normalized by 
antioxidant and vitamin food fortification is warranted.
We have demonstrated that paternal under-nutrition impairs pancreatic gene expression and lipid homeosta-
sis in offspring, with sex specific effects on adiposity, fat accumulation that suggest an increased risk of obesity in 
response to an obesogenic environment or with aging. Furthermore vitamin and antioxidant food fortification in 
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fathers, normalises the expression of some genes in the pancreas of female offspring, rescues ROS and somewhat 
normalised global methylation patterns in sperm, normalised postnatal growth and associated adiposity in male 
and female offspring, with sex specific improvements to circulating lipids in females and insulin sensitivity in 
males, albeit transiently. This proof of concept study identifies the undernourished father as a novel source of the 
global disease burden and as a modifiable target in its prevention through food fortification, that likely acts in 
concert with the detrimental maternal under-nutrition pathways. Whether similar benefits will be observed in 
humans and the direct mode of transmission warrants further investigation.
Methods
Animal Ethics. This study was carried out in strict accordance with the Australian code of practice for the 
care and use of animals for scientific purposes. The use and care of all animals used in the study was approved by 
the Animal Ethics Committee of The University of Adelaide.
Founder Males and Diets. C57BL6 male mice (5 weeks old) were fed either a control diet (CD, n = 10), 
containing 6% fat, 19% protein and 64.7% carbohydrate, a restricted diet (DR, n = 10) or a restricted diet with 
vitamin and antioxidant supplementation (DRVO) for 17 weeks (Table S1). The diet for DRVO was supplemented 
with vitamin C, vitamin E, folate, lycopene, zinc, selenium and green tea extract for the vitamin intervention. 
For diet restriction C57Bl6 male mice were restricted to 70% of ad libitum intake of the control diet, using a 
step-down protocol, with restriction to 90% for the first week, 80% in the second week, 70% in the third week 
then maintained at 70% ad libitum intake for a further 14 weeks (22 weeks of age). A control diet with antioxidant 
supplementation (CDVO) cohort was also included, but not mated. Animals were individually housed for the 
entire study and had water supplied at all times.
Founder Body Composition. Founder body weights were recorded weekly. At 22 weeks of age adiposity 
(gonadal adiposity, omental adiposity, retroperitoneal adiposity, peritoneal adiposity and dorsal adiposity), liver 
and pancreas were collected, weighed and performed blinded by the same individual.
Founder Glucose Tolerance Test (GTT) and Insulin Tolerance Test (ITT). At 20 weeks of age a GTT 
was performed after 6 h of fasting by intra-peritoneal (IP) injection of 2 g/kg of 25% D-glucose solution. ITT 
was performed at 22 weeks of age during a fed state by IP injection of 1.0 IU of human insulin (Actapid® , Novo 
Nordisk, Bagsvaerd, Denmark). Tail blood glucose concentrations were measured using a glucometer (Hemocue, 
Angelholm, Sweden) at time points 0 (pre-bolus basal), 15, 30, 60 and 120 min. Data were expressed as mean 
blood glucose concentration per group as area under curve (AUC) for glucose and area above the curve (AAC) 
for insulin.
Founder Sperm Count, Motility and Morphology. Sperm count, motility and morphology were 
assessed in accordance with WHO guidelines28 (at least 200 sperm counted for each sample). Sperm count was 
determined by counting on a haemocytometer. Sperm motility was assessed blinded under a light microscope 
classifying 200 sperm per animal as either progressive motile, non-progressive motile or immotile. Motility was 
then expressed as percentage of total motile sperm (progressive motile + non progressive motile sperm). Sperm 
morphology was assessed blinded on samples fixed with methanol:acetone (3:1) and stained with haematoxylin 
and eosin. For identifying sperm morphology individual sperm were classified as normal, tail defect (bent tails 
and twisted tails) or head defect (large heads, small heads and deformed heads) as per9. Morphology is expressed 
as percentage normal forms.
Founder Sperm Binding. Sperm binding to the zona pellucida were performed as described in Bakos 
et al.50. Briefly mature cumulus-enclosed oocytes (COCs) were collected from 4-week old Swiss female mice 12 h 
following super ovulation with intraperitoneal injections of PMSG and hCG administered 48 h apart. Sperm 
(1 × 104/ml) were co-incubated with COCs in G-IVF for 1 hr at 37 °C, 6% CO2 and 5% O2. At 1 hr post insemina-
tion, sperm binding was determined by counting the number of bound sperm to the oocyte under phase contrast 
microscopy. At least 10 oocytes were analysed per sperm sample.
Intracellular Sperm Reactive Oxygen Species (DCFDA). Intracellular ROS levels were assessed in pro-
gressively motile sperm by incubation with 1μ M DCFDA (2′ ,7′ -dichlorodihydrofluorescein diacetate, Invitrogen) 
for 20 min at 37 °C as per51. Sperm were then washed twice and imaged using a fluorescent microscope with pho-
tometer attachment. Intracellular ROS levels were expressed as average fluorescent units (FU).
Sperm Immunocytochemistry. Oxidative stress induced DNA lesions in sperm was assessed by oxida-
tive guanine DNA (8-OH-dG) stained sperm modified from52 while global sperm methylation was assessed by 
5-methylcytosine (5mC). Sperm were fixed to polylysine slides with 3:1 ratio of methanol to acetone for 5 mins 
and then permeabilised for 45 min in 0.5% Triton-X-100. Slides were then washed in PBS and sperm nuclei 
decondensed for 60 min at 37 °C in 1M HCL, 10 mM Tris buffer containing 5 mM dithioretiol. Sperm nuclei 
were then denatured in 6M HCL/0.1% Triton-X-100 for 45 min at room temperature followed by neutralisation 
in 100 μ M Tris HCL. Sperm slides were then incubated in either 1:100 mouse Anti-8 Hydroxyguanosine anti-
body [N45.1] (ab48508, Abcam, Cambridge, UK) or 1:00 mouse Anti-5mC (39649, Active Motif, Carlsbad, USA) 
in 10% donkey serum overnight at 4 °C followed by PBS washes and incubation in 1:100 Biotin-SP-conjugated 
AffiniPure F(ab’)2 fragmented donkey anti-mouse IgG (H + L) (715-065-150, Jackson ImmunoResearch, 
Baltimore, PA, USA) at room temperature for 2 h. Following PBS washes sperm slides were then incubated in 
1:100 Cy3 conjugated streptavidin (016-160-084, Jackson ImmunoResearch) for 1.5 h at room temperature 
followed by nuclear counter staining with Hoechst. Slides were loading in glycerol/prolong gold solution and 
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imaged under epifluorescent microscopy. For 8-OH-dG staining a positive control was included where by sperm 
were treated prior to fixation with 1500 μ M H2O2 to induce sperm oxidative DNA lesions. For both 8-OH-dG 
and 5mC staining a negative control was added where the primary antibodies were omitted from the reaction. 
For 8-OH-dG staining 200 sperm per animal were assessed as either positive for 8-OH-dG staining or negative 
(Fig. S4) and this expressed as a percentage. For the 8-OH-dG positive control 99% of sperm were positively 
stained for 8-OH-dG while no sperm stained positive in the negative control. As there were very low levels of 
5mC present in mouse sperm, 200 sperm per animal were viewed and classified as either positive for 5mC stain-
ing or negative.
Embryo Collection. 3–4 week old C57BL6 female mice who were fed standard chow were given an intra-
peritoneal (IP) injection of 5 IU Pregnant Mare’s Serum Gonadotropin (PMSG) (Folligon, Invervet, Bendigo, 
Australia), followed 48 h later with an IP injection of 5 IU human Chorionic Gonadotropin (hCG) (Pregnyl, 
Organon, Sydney, Australia) to induce ovulation as per53,54. Following the hCG injection female mice were indi-
vidually placed with a founder male at 13 weeks of age (8 weeks on restricted diets). Successful mating was 
assessed the following morning by the presence of a vaginal plug. At 22–24 h post hCG female mice were humanly 
killed by cervical dislocation and, cumulus enclosed zygotes were collected and placed in MOPS (Vitrolife) at 
37 °C and denuded of cumulus cells by 1 min incubation with 0.5 mg/ml hyaluronidase. Zygotes were washed 
twice in MOPS and once in G1 medium before culture in G1 media.
Embryo Culture. Embryos were cultured in groups of 10 in 20 μ l drops of either G1 (Vitrolife) under par-
affin oil (Merck, New Jersey, USA) for the first 48 h at 37oC in 5% O2, 6% CO2 and 89% N2. Embryos were then 
washed and cultured in G2 (Vitrolife) for a further 48 h to the blastocyst stage. Blastocyst development was scored 
at 20 h culture (cleavage), 42 h culture (compaction), 78 h culture (early blastocyst) and 96 h culture (late blasto-
cyst) was scored at 96 h of culture (late blastocyst). Development post 20 h was expressed as percentage of on time 
embryos as a proportion of 2-cell cleavage. All embryo culture dishes were prepared 4 h prior to embryo culture 
to allow for gassing and temperature equilibration.
Blastocyst Cell Number and Differentiation. Allocation of cells to the trophectoderm (TE) and inner 
cell mass (ICM) in the blastocyst, was performed at 96 h of culture as previously described55. Briefly, blasto-
cysts were placed into 0.5% pronase (Sigma) at 37 °C until the zona pellucida dissolved, before incubation in 
10 μM of 2,4,6-trinitrobenzenesulfonic acid (TNBS, Sigma) at 4 °C for 10 minutes. Blastocysts were transferred 
into 0.1 mg/μ l anti-dinitrophenyl- BSA (anti-DNP, Sigma) for 10 minutes at 37 °C and then placed in guinea pig 
serum (Sigma) with PI (Sigma) for 5 minutes at 37 °C. Finally, embryos were placed in bisbenzimide (Sigma) at 
4 °C overnight. The following day the embryos were washed through 100% ethanol, mounted in glycerol and 
visualized using a fluorescence microscope.
Mating to Produce F1 Offspring. Founder males were mated with normal weight naturally cycling 
C57BL6 females to generate F1 offspring. At 15 weeks of age (10 weeks on restricted diets), each male was allo-
cated 2, 8–9 weeks old female to mate for a maximum period of 5 days. Both males and females were given access 
to ad libitum CD food during the natural mating (120 h) to limit under nutrition to the mother. Successful mating 
was assessed the following morning by the presence of a vaginal plug. Females who had successfully been mated 
were removed and fed ad libitum standard chow whilst the founder males returned to their treatment group. On 
day 14 of pregnancy females were individually housed prior to birth. Females were monitored for birth from 18 
days gestation and birth date and litter numbers were recorded. Pups were tattooed on day 5 and weighed on days 
5, 7, 10, 14 and 21. On day 21 post birth, 2 males and 2 female offspring were sampled randomly per litter, weaned, 
ear tagged and allocated to share housing (5/offspring/per sex/per cage) until 15 weeks of life. Offspring were fed 
ad libitum standard chow routinely provided by the animal house and weighed weekly. 14 females and 14 males 
were sampled from 7 litters generated from 6 founders for CD group, 12 females and 12 males sampled from 6 
litters generated from 6 founders for DR group, and 16 females and 16 males samples from 8 litters generated 
from 8 founders for the DRVO group.
F1 Offspring Body Composition. Pre weaning body weights were recorded on days 5, 7, 10, 12, 14 and 
21 post birth and identification of individual pups was determined by a foot pad tattoo. Post weaning offspring 
received an identifiable ear tag and body weights were recorded up until 15 weeks of age. At 8 weeks and 14 
weeks of age offspring underwent a dual-emission X-ray absorptiometry machine (DEXA) (Piximus, Ge Lunar, 
Wisconsin, USA) as previously described in56 to determine, bone, lean mass and adiposity body composition. At 
15 weeks of age offspring underwent a full post mortem where adiposity (gonadal adiposity, omental adiposity, 
retro peritoneal adiposity, peritoneal adiposity and dorsal adiposity), liver, kidneys and pancreas were collected, 
weighed and performed blinded by the same individual.
F1 Offspring GTT and ITT. At 8–9 weeks and 13–14 weeks offspring underwent repeated measures for 
glucose and insulin challenges respectively as described above (For ITT females were given a bolus of 0.75 IU of 
human insulin while male offspring were given a bolus of 1.0 IU). A 5 day break was given to each mouse between 
each test at each time point.
Metabolites and Hormone Analysis. At 22 weeks of age for founder males and 15 weeks of age for F1 
offspring overnight fasting blood serum was collected post mortem by a cardiac puncture under anaesthetic with 
2% Isoflurane(1-chloro-2,2,2-trifluoroethyldifluoromethylether, Veterinary Companies of Australia, Kings Park, 
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Australia). Serum cholesterol, free fatty acids (FFA), glucose, triglycerides and high-density lipoprotein were 
measured on a Cobas Integra 400 plus automated sampler system (Roche, Basel, Switzerland). Serum insulin and 
leptin levels were measured by either an Ultra-Sensitive Mouse Insulin ELISA Kit (#90080, Crystal Chem Inc, 
Downer Grove, Illinois, USA) or Mouse Leptin ELISA Kit (#90030, Crystal Chem Inc, Downer Grove, Illinois, 
USA as per the manufacturer instructions.
Histology of F1 Offspring Omental Adiposity. F1 offspring omental adiposity was fixed overnight in 4% 
paraformaldehyde and stored in 70% ethanol until further use. Omental adiposity was embedded in wax using 
standard methods and 7 μ m sections were cut and heat fixed onto super frost slides. Each slide contained four 7 μ m 
sections 50 μ m apart. Slides were dewaxed, rehydrated in ethanol dilutions and stained with haematoxylin and 
eosin as per standard methods. Slides were mounted in DPX mounting media and imaged using a NanoZoomer 
slide scanner (Hamamatsu Photonics, Sunayama-cho, Naka-ku, Japan). The areas of 100 adipocytes from at least 
5 different sections per animal were measured using NanoZoomer NDP viewer software. Adipocyte cell number 
was determined by counting the number of visible adipocytes in an 8000 μ m2 square in 9 different areas of tissue 
across 2–3 sections. Adipocyte size and number was determined in 4 male and female offspring representative of 
4 litters and 4 founder males.
RNA Sequencing of offspring pancreases. RNA was extracted from 6 adult (15 weeks of age) male/
female mouse pancreases per paternal diet treatment using a Qiagen RNeasy mini kit (Qiagen. Hilden, Germany). 
rRNA depletion and random hexamers were used to make cDNA libraries (New England Biolabs, Ipswich, 
Massachusetts, USA) which were then sequenced (50 bp single-end, stranded) on an Illumina HiSeq 2500 
(Illumina, San Diego, California, USA) by the SA cancer genomic facility (IMVS, Adelaide, Australia). Sequence 
reads were mapped to the mm10 build of the mouse genome with tophat v2.0.957 and read counts per gene calcu-
lated with htseq-count58. RNA-Seq data was analysed with the edgeR package from bioconductor59. Genes with 
counts per million model mapped reads of less than 1 were filtered out as were reads with multiple mapping loca-
tions and those not mapping to known features. Differential expression was determined between groups by first 
fitting a generalised linear model to these data incorporating diet of the father, sex of the mouse and RIN scores 
as covariates. Differences between groups with fathers fed under different diet conditions were determined by log 
rank test, correcting for multiple testing with the false discovery rate method59.
Statistics. All data were expressed as mean ± SEM and checked for normality using a Kolmogorov-Smirnov 
test and equal variance using a Levene’s test. Statistical analysis was performed in SPSS (SPSS Version 18, SPSS 
Inc., Chicago, USA) with AUC and AAC calculated in GraphPad Prism (GraphPad Software, San Diego, USA). 
A p value < 0.05 was considered to be significant. Founder measures were analysed by a one way ANOVA with 
Bonferroni post hoc test. Embryology was assessed by a Fishers Exact test. Offspring post mortems, fat cell size 
and metabolites were assessed by linear mixed modelling with a Bonferroni post hoc test. Offspring weights, GTT, 
ITT and DEXA were analysed using a Repeated Measures ANOVA with Bonferroni post hoc test. In the models 
founder ID and mother ID were added as random effects to adjust for dependence in results between offspring 
from the same father and same mother. Replicate was fitted as a covariate. Correlations were determined by a 
Pearson correlation for founder measures or a linear regression controlling for multiple observations for individ-
ual fathers for offspring measures.
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